(Q24197830)

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

Line-item analysis of the Aberrant Behavior Checklist: results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

Aripiprazole to treat irritability associated with autism: a placebo-controlled, fixed-dose trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

Aripiprazole for irritability associated with autistic disorder in children and adolescents aged 6-17 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

Aripiprazole in autism spectrum disorders and fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

Aripiprazole for the treatment of irritability associated with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

Aripiprazole monotherapy in children and young adolescents with pervasive developmental disorders: a retrospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

Aripiprazole for maladaptive behavior in pervasive developmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

Prevalence of autism-spectrum conditions: UK school-based population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

The effects of haloperidol on learning and behavior in autistic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

Meta-analyses involving cross-over trials: methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

Aripiprazole: profile on efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

Risperidone for autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

Prevalence of parent-reported diagnosis of autism spectrum disorder among children in the US, 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

Behavioral and emotional problems in young people with pervasive developmental disorders: relative prevalence, effects of subject characteristics, and empirical classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

Management of Children With Autism Spectrum Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

Antipsychotics in the treatment of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

Systematic review of prevalence studies of autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

Aripiprazole versus other atypical antipsychotics for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

inferred from DOI database lookup

7 January 2021

based on heuristic

2-year-old boy who has been diagnosed with autism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009043.PUB2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/14651858.CD009043.PUB2

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

22592735

1 reference

Consolidated OpenCitations Corpus – April 2017